← All stocks

HEALTHEQUITY, INC.

HQY Net selling

CIK 0001428336 #1006 in the set updated 18 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$5.08M

$2.43M on a plan · $1.44M straight out of an exercise

Sold at will

$1.20M

2 of 16 sales

Net

−$5.08M

−$1.20M against sales at will

By person

17 insiders · 16 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ladd Delano

EVP, General Counsel

—

$1.68M (7) scheduled

−$1.68M

90,054

0.1077%

$9.48M

+58.4%

Rosner Elimelech

EVP, CHIEF TECHNOLOGY OFFICER

—

$1.05M (1)

−$1.05M

81,497

0.0975%

$8.58M

+30.4%

Fiore Michael Henry

EVP, CHIEF COMMERCIAL OFFICER

—

$913.87K (4) scheduled

−$913.87K

52,244

0.0625%

$5.50M

−4.8%

DILLON ADRIAN T

Director

—

$798.37K (2) scheduled

−$798.37K

62,395

0.0746%

$6.57M

+8.5%

Wellborn Gayle Furgurson

Director

—

$644.84K (2) scheduled

−$644.84K

22,610

0.0270%

$2.38M

+27.5%

Kessler Jon

Former Director

—

328,510

0.3929%

$34.58M

+7.4%

Neeleman Stephen

FOUNDER AND VICE CHAIRMAN

—

277,565

0.3320%

$29.22M

+16.0%

Cutler Scott

President and CEO

—

176,405

0.2110%

$18.57M

+128.4%

Lucania James M

EVP & CFO

—

104,617

0.1251%

$11.01M

+30.9%

SELANDER ROBERT W

Director

—

89,849

0.1075%

$9.46M

+87.3%

Dilsaver Evelyn S

Director

—

51,085

0.0611%

$5.38M

+47.4%

Gathright Michael

Chief Customer Officer

—

39,893

0.0477%

$4.20M

+47.7%

Parker Stuart B.

Director

—

25,975

0.0311%

$2.73M

−41.0%

Natarajan Rajesh

Director

—

18,130

0.0217%

$1.91M

+57.6%

McCowan Debra Charlotte

Director

—

12,659

0.0151%

$1.33M

−0.9%

Corvino Frank

Former Director

—

3,784

0.0045%

$398.29K

−37.7%

Gassen William

Director

—

3,611

0.0043%

$380.08K

+392.0%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 57

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 10

Sales straight out of an exercise 4

Sales at will 2

Transactions with no price 0

Shares from compensation/vesting 686,448

History held since 1 Sep 2016